In the last 12 months, insiders at Microbot Medical Inc. ($MBOT) filed 46 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
Microbot Medical Inc. operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Laxminarain Prattipati (Director) — 3 transactions totaling $0
- Bornstein Yoseph (Director) — 1 transaction totaling $0
- Madden Martin J. (Director) — 3 transactions totaling $0
- Morag Eyal (Chief Medical Officer) — 2 transactions totaling $0
- Sharon Simon (General Manager, CTO) — 7 transactions totaling $0
View all SEC Filings for Microbot Medical Inc. (MBOT).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Burell Scott R | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 67,158,044 | 9999.99% | 0.01% |
| April 1, 2026 | Wilson David James | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 67,158,044 | 9999.99% | 0.01% |
| April 1, 2026 | Wenderow Tal Baruch | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 67,158,044 | 9999.99% | 0.01% |
| April 1, 2026 | Stockburger Aileen Ptucha | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 67,158,044 | 9999.99% | 0.01% |
| April 1, 2026 | Madden Martin J. | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 67,158,044 | 9999.99% | 0.01% |
| April 1, 2026 | Laxminarain Prattipati | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 67,158,044 | 9999.99% | 0.01% |
| Feb. 18, 2026 | Gadot Harel | Chairman, President and CEO | A | Stock Option (Right to Buy) | 480000 | $0.00 | 480,000.0000 | 67,158,044 | 9999.99% | 0.71% |
| Feb. 18, 2026 | Diaz-Cartelle Juan | Chief Medical Officer | A | Stock Option (Right to Buy) | 105000 | $0.00 | 105,000.0000 | 67,158,044 | 9999.99% | 0.16% |
| Feb. 18, 2026 | Sharon Simon | General Manager, CTO | A | Stock Option (Right to Buy) | 105000 | $0.00 | 105,000.0000 | 67,158,044 | 9999.99% | 0.16% |
| Feb. 18, 2026 | Vaknin Rachel | Chief Financial Officer | A | Stock Option (Right to Buy) | 105000 | $0.00 | 105,000.0000 | 67,158,044 | 9999.99% | 0.16% |
| Feb. 5, 2025 | Vaknin Rachel | Chief Financial Officer | A | Stock Option (Right to Buy) | 48125 | $0.00 | 48,125.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Vaknin Rachel | Chief Financial Officer | A | Stock Option (Right to Buy) | 4375 | $0.00 | 4,375.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | Gadot Harel | Chairman, President and CEO | A | Stock Option (Right to Buy) | 228000 | $0.00 | 228,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Gadot Harel | Chairman, President and CEO | A | Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | Sharon Simon | General Manager, CTO | A | Stock Option (Right to Buy) | 43750 | $0.00 | 43,750.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Sharon Simon | General Manager, CTO | A | Stock Option (Right to Buy) | 8750 | $0.00 | 8,750.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | Diaz-Cartelle Juan | Chief Medical Officer | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Diaz-Cartelle Juan | Chief Medical Officer | A | Stock Option (Right to Buy) | 10500 | $0.00 | 10,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 28, 2025 | Wenderow Tal Baruch | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 28, 2025 | Stockburger Aileen Ptucha | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 28, 2025 | Wilson David James | Director | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 28, 2025 | Laxminarain Prattipati | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 28, 2025 | Madden Martin J. | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 28, 2025 | Burell Scott R | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2024 | Vaknin Rachel | Chief Financial Officer | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2024 | Gadot Harel | Chairman, President and CEO | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2024 | Gadot Harel | Chairman, President and CEO | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Gadot Harel | Chairman, President and CEO | A | Stock Option (Right to Buy) | 79567 | $0.00 | 79,567.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2024 | Vaknin Rachel | Chief Financial Officer | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2024 | Sharon Simon | General Manager, CTO | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2024 | Sharon Simon | General Manager, CTO | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2024 | Diaz-Cartelle Juan | Chief Medical Officer | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| Nov. 2, 2023 | Wenderow Tal Baruch | Director | A | Stock Option (Right to Buy) | 74218 | $0.00 | 74,218.0000 | 0 | 9999.99% | 0.00% |
| Nov. 2, 2023 | Madden Martin J. | Director | A | Stock Option (Right to Buy) | 74218 | $0.00 | 74,218.0000 | 0 | 9999.99% | 0.00% |
| Nov. 2, 2023 | Laxminarain Prattipati | Director | A | Stock Option (Right to Buy) | 74218 | $0.00 | 74,218.0000 | 0 | 9999.99% | 0.00% |
| Nov. 2, 2023 | Burell Scott R | Director | A | Stock Option (Right to Buy) | 74218 | $0.00 | 74,218.0000 | 0 | 9999.99% | 0.00% |
| Nov. 2, 2023 | Stockburger Aileen Ptucha | Director | A | Stock Option (Right to Buy) | 74218 | $0.00 | 74,218.0000 | 0 | 9999.99% | 0.00% |
| Nov. 2, 2023 | Bornstein Yoseph | Director | A | Stock Option (Right to Buy) | 74218 | $0.00 | 74,218.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Vaknin Rachel | Chief Financial Officer | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Gadot Harel | Chairman, President and CEO | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Sharon Simon | General Manager, CTO | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Morag Eyal | Chief Medical Officer | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2023 | Morag Eyal | Chief Medical Officer | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2023 | Sharon Simon | General Manager, CTO | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 21, 2022 | Gadot Harel | Chairman, President and CEO | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 21, 2022 | Vaknin Rachel | Chief Financial Officer | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |